EUVIMEDEUVIMED entdecken
Crossref

Unraveling neurovascular disease risk with MultiVINE-seq

Lynn van Olst, David Gate

Neuron · 2025

DOI: 10.1016/j.neuron.2025.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025. Verfasst von Lynn van Olst und 1 weiteren Autor:innen. Beteiligte Einrichtung: Abrams Research Center on Neurogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; The Ken & Ruth Davee Department of Ne…. Hauptthemen laut MEDLINE: Cerebrovascular Disorders, Neurodegenerative Diseases. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of Neuron, Reid et al. introduce MultiVINE-seq, a single-nucleus multi-omic platform for profiling human cerebrovascular and perivascular cells for paired transcriptomic and epigenomic profiling.1 By integrating genome-wide association data, they map neurodegenerative and cerebrovascular disease risk variants to specific vascular and immune cell types, uncovering distinct and convergent pathogenic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebrovascular DisordersNeurodegenerative DiseasesHumansGenome-Wide Association StudyTranscriptomeGene Expression Profiling

Autor:innen und Institutionen

  • Abrams Research Center on Neurogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; The Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago,…

Zitieren

APA

van Olst, L., & Gate, D. (2025). Unraveling neurovascular disease risk with MultiVINE-seq. Neuron. https://doi.org/10.1016/j.neuron.2025.09.016

Vancouver

van Olst L, Gate D. Unraveling neurovascular disease risk with MultiVINE-seq. Neuron. 2025. doi:10.1016/j.neuron.2025.09.016

BibTeX
@article{vanOlst2025,
  author = {van Olst, Lynn and Gate, David},
  title = {Unraveling neurovascular disease risk with MultiVINE-seq},
  journal = {Neuron},
  year = {2025},
  doi = {10.1016/j.neuron.2025.09.016}
}
Kostenlos starten →